Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children’s Hospital experience

被引：0
|
作者：
Erin E. Crotty
Sarah E. S. Leary
J. Russell Geyer
James M. Olson
Nathan E. Millard
Aimee A. Sato
Ralph P. Ermoian
Bonnie L. Cole
Christina M. Lockwood
Vera A. Paulson
Samuel R. Browd
Richard G. Ellenbogen
Jason S. Hauptman
Amy Lee
Jeffrey G. Ojemann
Nicholas A. Vitanza
机构：
[1] University of Washington,Division of Hematology/Oncology, Department of Pediatrics, Seattle Children’s Hospital
[2] Fred Hutchinson Cancer Research Center,Division of Pediatric Neurology, Department of Neurology
[3] University of Washington,Department of Radiation Oncology
[4] University of Washington,Department of Laboratories, Seattle Children’s Hospital
[5] University of Washington,Department of Anatomic Pathology
[6] University of Washington School of Medicine,Department of Laboratory Medicine, Genetics and Solid Tumor Diagnostics Laboratory
[7] University of Washington and Seattle Children’s Hospital,Division of Neurosurgery, Department of Neurological Surgery, Seattle Children’s Hospital
[8] University of Washington,undefined
来源：
Journal of Neuro-Oncology | 2020年 / 148卷
关键词：
Pediatric high-grade glioma; Diffuse intrinsic pontine glioma; Temozolomide; Irinotecan; Bevacizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：607 / 617
页数：10
相关论文
共 50 条
  • [1] Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience
    Crotty, Erin E.
    Leary, Sarah E. S.
    Geyer, J. Russell
    Olson, James M.
    Millard, Nathan E.
    Sato, Aimee A.
    Ermoian, Ralph P.
    Cole, Bonnie L.
    Lockwood, Christina M.
    Paulson, Vera A.
    Browd, Samuel R.
    Ellenbogen, Richard G.
    Hauptman, Jason S.
    Lee, Amy
    Ojemann, Jeffrey G.
    Vitanza, Nicholas A.
    JOURNAL OF NEURO-ONCOLOGY, 2020, 148 (03) : 607 - 617
  • [2] SURVIVAL OF PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA TREATED WITH TEMOZOLOMIDE, IRINOTECAN AND BEVACIZUMAB AT SEATTLE CHILDREN'S HOSPITAL
    Uparkar, Urmila
    Geyer, Russell
    Ermoian, Ralph
    Ellenbogen, Richard
    Leary, Sarah
    NEURO-ONCOLOGY, 2012, 14 : 62 - 62
  • [3] TREATMENT OF CHILDREN WITH RECURRENT OR PROGRESSIVE HIGH-GRADE GLIOMAS WITH IRINOTECAN, TEMOZOLOMIDE, AND BEVACIZUMAB
    Parekh, Chintan
    Jubran, Rima
    Finlay, Jonathan
    Dhall, Girish
    NEURO-ONCOLOGY, 2008, 10 (05) : 834 - 834
  • [4] TREATMENT OF CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) WITH INTENSIVE CHEMORADIOTHERAPY FOLLOWED BY IRINOTECAN, TEMOZOLOMIDE AND BEVACIZUMAB
    Dhall, Girish
    Bluml, Stefan
    Panigrahy, Ashok
    Nelson, Marvin
    Marachelian, Araz
    Finlay, Jonathan
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 833 - 833
  • [5] COMBINATION OF BEVACIZUMAB AND TEMOZOLOMIDE IN CHILDREN WITH PRIMARY HIGH-GRADE GLIOMAS
    Kholodov, Boris
    Valiakhmetova, Andge
    Tarasova, Ekaterina
    Gorelishev, Sergey
    Ryzhova, Marina
    Trunin, Yuri
    Roumyantsev, Sergey
    Matuev, Kaspot
    NEURO-ONCOLOGY, 2017, 19 : 24 - 24
  • [6] Phase II trial of temozolomide in children with recurrent high-grade glioma
    A. Ruggiero
    G. Cefalo
    M.L. Garré
    M. Massimino
    C. Colosimo
    G. Attinà
    I. Lazzareschi
    P. Maurizi
    V. Ridola
    G. Mazzarella
    M. Caldarelli
    C. Di Rocco
    E. Madon
    M.E. Abate
    A. Clerico
    A. Sandri
    R. Riccardi
    Journal of Neuro-Oncology, 2006, 77 : 89 - 94
  • [7] Phase II trial of temozolomide in children with recurrent high-grade glioma
    Ruggiero, A.
    Cefalo, G.
    Garre, M. L.
    Massimino, M.
    Colosimo, C.
    Attina, G.
    Lazzareschi, I.
    Maurizi, P.
    Ridola, V.
    Mazzarella, G.
    Caldarelli, M.
    Di Rocco, C.
    Madon, E.
    Abate, M. E.
    Clerico, A.
    Sandri, A.
    Riccardi, R.
    JOURNAL OF NEURO-ONCOLOGY, 2006, 77 (01) : 89 - 94
  • [8] Vorinostat, temozolomide or bevacizumab with irradiation and maintenance BEV/TMZ in pediatric high-grade glioma: A Children's Oncology Group Study
    Lulla, Rishi R.
    Buxton, Allen
    Krailo, Mark D.
    Lazow, Margot A.
    Boue, Daniel R.
    Leach, James L.
    Lin, Tong
    Geller, James, I
    Kumar, Shiva Senthil
    Nikiforova, Marina N.
    Chandran, Uma
    Jogal, Sachin S.
    Nelson, Marvin D.
    Onar-Thomas, Arzu
    Haas-Kogan, Daphne A.
    Cohen, Kenneth J.
    Kieran, Mark W.
    Gajjar, Amar
    Drissi, Rachid
    Pollack, Ian F.
    Fouladi, Maryam
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
  • [9] Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma
    Verhoeff, J. J. C.
    Lavini, C.
    van Linde, M. E.
    Stalpers, L. J. A.
    Majoie, C. B. L. M.
    Reijneveld, J. C.
    van Furth, W. R.
    Richel, D. J.
    ANNALS OF ONCOLOGY, 2010, 21 (08) : 1723 - 1727
  • [10] Temozolomide after Radiotherapy for Newly Diagnosed High-grade Glioma and Unfavorable Low-grade Glioma in Children
    Alberto Broniscer
    Murali Chintagumpala
    Maryam Fouladi
    Matthew J. Krasin
    Mehmet Kocak
    Daniel C. Bowers
    Lisa C. Iacono
    Thomas E. Merchant
    Clinton F. Stewart
    Peter J. Houghton
    Larry E. Kun
    Davonna Ledet
    Amar Gajjar
    Journal of Neuro-Oncology, 2006, 76 : 313 - 319
12345